LEF1 and precursor B-cell acute lymphoblastic leukemia: This observation identified LEF1 as an oncogene, and may have a clinical impact, since LEF1 was found overexpressed in more than 25% of cases of B-ALL in a large cohort of adult patients, and represented an independent adverse prognostic factor [98].